IOL Chemicals and Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 5,234.8 million. Revenue was INR 5,301.3 million. Net income was INR 237.9 million. Basic earnings per share from continuing operations was INR 4.05.
For the nine months, sales was INR 16,299 million. Revenue was INR 16,467.8 million. Net income was INR 743.7 million. Basic earnings per share from continuing operations was INR 12.67.